TAO Synergies Inc. (TAOX) Stock Score, Valuation & Financial Research

TAO Synergies Inc. is in the Technology sector and Software - Application industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 34/100.

Quick answer for TAOX

TAO Synergies Inc. currently has a Wall Street Score of 34/100. The stored market price is $4.57. Its financial score is 27/100. Its valuation score is 0/100. The latest WSS change is -3.3 points. These figures are a research snapshot, not a buy or sell recommendation.

What TAO Synergies Inc. does

TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.

TAOX financial snapshot

Wall Street Score:
34/100
Current price:
$4.57
Market capitalization:
$34.1M
Revenue:
$772K
Net income:
$-16.7M
Free cash flow:
$-6.4M
Cash:
$2.4M
Total debt:
$0
EPS:
-3.98
Financial score:
27/100
Valuation score:
0/100

What stands out

  • Reported year-over-year revenue growth is +1.6%.
  • Free cash flow is $-6.4M, showing cash burn in the current stored period.
  • The balance sheet shows $2.4M of cash versus $0 of total debt, leaving more cash than debt.
  • The latest Wall Street Score change is -3.3 points: TAOX decreased 3.3 points because Asset declined by 20.4 points, Capital declined by 13 points.
  • The current research record carries a share basis reconciled warning, which should be reviewed alongside the score.

Questions worth answering for TAOX

These questions are derived from the company's current stored financial and score data so the page adds company-specific research context instead of treating the headline score as a stand-alone conclusion.

  • Can TAOX maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • How long can TAOX fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • How is TAOX likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
  • What specifically needs to improve for TAOX to reach sustainable profitability?
  • What future growth or profitability would be needed to justify TAOX's current valuation?

What the numbers mean

Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.

The financial score is 27/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.

A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.

Data freshness: Financial data last refreshed 2026-09-19.

Research-input completeness: 82% of the scoring inputs required for this public page are currently available.

How to research TAOX

Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.

Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks

Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.